H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 80 Citations 24,041 276 World Ranking 9703 National Ranking 5203

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Immune system

His scientific interests lie mostly in COPD, Lung, Internal medicine, Immunology and Lung microbiome. The COPD study combines topics in areas such as Chest ct, Prospective cohort study and Spirometry. His Lung study combines topics in areas such as Pneumocystis carinii, Pneumonia, Radiology, Bronchoscopy and Pathology.

His studies in Internal medicine integrate themes in fields like Physical therapy, Intensive care medicine and Cardiology. As a part of the same scientific family, Jeffrey L. Curtis mostly works in the field of Immunology, focusing on Cryptococcus neoformans and, on occasion, Cryptococcosis, Virulence, In vivo, Melanin and Immunity. He has included themes like Bronchoalveolar lavage and Respiratory tract in his Lung microbiome study.

His most cited work include:

  • Azithromycin for Prevention of Exacerbations of COPD (806 citations)
  • Chronic obstructive pulmonary disease phenotypes: the future of COPD. (752 citations)
  • Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD (611 citations)

What are the main themes of his work throughout his whole career to date?

His main research concerns COPD, Internal medicine, Immunology, Lung and Cohort. His study in COPD is interdisciplinary in nature, drawing from both Pulmonary disease, Exacerbation, Physical therapy and Spirometry. His research in Internal medicine intersects with topics in Gastroenterology and Cardiology.

His Immunology research focuses on Bronchoalveolar lavage and how it connects with Microbiome. His specific area of interest is Lung, where Jeffrey L. Curtis studies Lung microbiome. His work focuses on many connections between Immune system and other disciplines, such as Cryptococcus neoformans, that overlap with his field of interest in Cryptococcosis and Immunity.

He most often published in these fields:

  • COPD (51.44%)
  • Internal medicine (45.95%)
  • Immunology (43.34%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (45.95%)
  • COPD (51.44%)
  • Cohort (15.93%)

In recent papers he was focusing on the following fields of study:

Jeffrey L. Curtis mostly deals with Internal medicine, COPD, Cohort, Lung and Immunology. His Internal medicine research includes themes of Gastroenterology and Cardiology. His COPD research incorporates elements of Pulmonary disease, Exacerbation, Spirometry and Airway.

His work in Cohort tackles topics such as Lung function which are related to areas like Chest ct and Radiology. He mostly deals with Bronchoalveolar lavage in his studies of Lung. His Immunology research is multidisciplinary, incorporating perspectives in Phenotype and Gene expression.

Between 2018 and 2021, his most popular works were:

  • Noninvasive Imaging Biomarker Identifies Small Airway Damage in Severe Chronic Obstructive Pulmonary Disease. (39 citations)
  • Metoprolol for the Prevention of Acute Exacerbations of COPD. (38 citations)
  • COPDGene® 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease. (31 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Immune system

His scientific interests lie mostly in COPD, Internal medicine, Lung, Cohort and Pulmonary disease. His work deals with themes such as Bronchitis and Randomized controlled trial, which intersect with COPD. His studies deal with areas such as Gastroenterology and Airway as well as Internal medicine.

His Lung study combines topics from a wide range of disciplines, such as Organ system and Reproducibility. His research integrates issues of Vital capacity, FEV1/FVC ratio and Multiplex in his study of Cohort. The study incorporates disciplines such as Small airways, Immunology and Intensive care medicine in addition to Pulmonary disease.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Azithromycin for Prevention of Exacerbations of COPD

Richard K. Albert;Richard K. Albert;John Connett;William C. Bailey;Richard Casaburi.
The New England Journal of Medicine (2011)

1279 Citations

Chronic obstructive pulmonary disease phenotypes: the future of COPD.

Mei Lan K. Han;Alvar Agusti;Peter M. Calverley;Bartolome R. Celli.
American Journal of Respiratory and Critical Care Medicine (2010)

1269 Citations

Analysis of the Lung Microbiome in the “Healthy” Smoker and in COPD

John R. Erb-Downward;Deborah L. Thompson;Meilan K. Han;Christine M. Freeman;Christine M. Freeman.
PLOS ONE (2011)

825 Citations

Comparison of the Respiratory Microbiome in Healthy Nonsmokers and Smokers

Alison Morris;James M. Beck;Patrick D. Schloss;Thomas B. Campbell.
American Journal of Respiratory and Critical Care Medicine (2013)

579 Citations

Predictors of mortality in patients with emphysema and severe airflow obstruction.

Fernando J. Martinez;Gregory Foster;Jeffrey L. Curtis;Gerard Criner.
American Journal of Respiratory and Critical Care Medicine (2006)

507 Citations

Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function

Prescott G. Woodruff;R. Graham Barr;Eugene Bleecker;Stephanie A. Christenson.
The New England Journal of Medicine (2016)

466 Citations

Chronic Obstructive Pulmonary Disease Exacerbations in the COPDGene Study: Associated Radiologic Phenotypes

MeiLan K. Han;Ella A. Kazerooni;David A. Lynch;Lyrica X. Liu.
Radiology (2011)

431 Citations

Analysis of the Upper Respiratory Tract Microbiotas as the Source of the Lung and Gastric Microbiotas in Healthy Individuals

Christine M. Bassis;John R. Erb-Downward;Robert P. Dickson;Christine M. Freeman.
Mbio (2015)

428 Citations

Pulmonary arterial enlargement and acute exacerbations of COPD.

J. Michael Wells;George R. Washko;Mei Lan K. Han;Naseer Abbas.
The New England Journal of Medicine (2012)

408 Citations

Gender and chronic obstructive pulmonary disease: why it matters.

Mei Lan K. Han;Dirkje Postma;David M. Mannino;Nicholas D. Giardino.
American Journal of Respiratory and Critical Care Medicine (2007)

405 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Jeffrey L. Curtis

Fernando J. Martinez

Fernando J. Martinez

Cornell University

Publications: 138

MeiLan K. Han

MeiLan K. Han

University of Michigan–Ann Arbor

Publications: 123

Edwin K. Silverman

Edwin K. Silverman

Brigham and Women's Hospital

Publications: 117

Alvar Agusti

Alvar Agusti

University of Barcelona

Publications: 102

Mark T. Dransfield

Mark T. Dransfield

University of Alabama at Birmingham

Publications: 101

Bartolome R. Celli

Bartolome R. Celli

Brigham and Women's Hospital

Publications: 96

Jørgen Vestbo

Jørgen Vestbo

University of Manchester

Publications: 93

George R. Washko

George R. Washko

Brigham and Women's Hospital

Publications: 91

Marc Miravitlles

Marc Miravitlles

Instituto de Salud Carlos III

Publications: 85

Gerard J. Criner

Gerard J. Criner

Temple University

Publications: 84

Gary B. Huffnagle

Gary B. Huffnagle

University of Michigan–Ann Arbor

Publications: 83

James D. Crapo

James D. Crapo

University of Colorado Denver

Publications: 77

Eric A. Hoffman

Eric A. Hoffman

University of Iowa

Publications: 75

David A. Lynch

David A. Lynch

Children's Hospital of Philadelphia

Publications: 72

Harvey O. Coxson

Harvey O. Coxson

University of British Columbia

Publications: 62

R. Graham Barr

R. Graham Barr

Columbia University

Publications: 60

Something went wrong. Please try again later.